Early cataract detection device to launch in January

Alphaeon Corporation today announced it has acquired an exclusive U.S. license from Visiometrics, S.L. to market the HD Analyzer, a device that assesses light scatter inside the eye.

Alphaeon expects to begin selling the FDA registered device in January 2014.

"This is a major breakthrough in our ability to evaluate patients,” said Alphaeon Chief Physician Officer Dan Durrie, MD. As a practicing refractive surgeon, the HD Analyzer has become my standard diagnostic procedure when examining a 40 to 60 year-old patient to determine whether I recommend a lens replacement or LASIK." 

According to Alphaeon, the HD Analyzer is used in several hundred ophthalmic centers internationally and clinical validation has been established in more than 20 peer-reviewed publications worldwide.